Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $335.0000 (-5.63%) ($335.0000 - $335.0000) on Fri. Feb. 27, 2009. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 13.62% (three month average) | RSI | 46 | Latest Price | $335.0000(-5.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -6.81% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.81% (StdDev 13.62%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $348.55 | 5 Day Moving Average | $329(1.82%) | 10 Day Moving Average | $342.52(-2.2%) | 20 Day Moving Average | $348.55(-3.89%) | To recent high | -44.2% | To recent low | 59.5% | Market Cap | $6.599b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |